Question 1

Does Westwood Holdings Group own HALOZYME THERAPEUTICS stock?

Accepted Answer

No. Westwood Holdings Group exited its HALOZYME THERAPEUTICS position in Q4 2025. Its Q3 2025 13F listed 1,000,000 shares worth $1.4M.

Question 2

How many shares of HALOZYME THERAPEUTICS does Westwood Holdings Group own?

Accepted Answer

None since Q4 2025, when Westwood Holdings Group exited the position. Its Q3 2025 13F listed 1,000,000 shares worth $1.4M.

Question 3

What is Westwood Holdings Group's HALOZYME THERAPEUTICS position worth?

Accepted Answer

Westwood Holdings Group's HALOZYME THERAPEUTICS position was worth $1.4M in its Q3 2025 13F, before the exit in Q4 2025.

Question 4

Is Westwood Holdings Group buying or selling HALOZYME THERAPEUTICS?

Accepted Answer

In Q4 2025, Westwood Holdings Group exited its entire HALOZYME THERAPEUTICS position.

Question 5

When did Westwood Holdings Group first buy HALOZYME THERAPEUTICS?

Accepted Answer

Westwood Holdings Group already held HALOZYME THERAPEUTICS in its Q3 2023 13F, the earliest on record, and listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price
2025-Q4 Latest	Exited	0	-100.0%	$0	0.0%	—
2025-Q3	Decreased	1M	-55.6%	$1.4M	0.0%	—
2025-Q2	Unchanged	2.3M	0.0%	$2.3M	0.0%	—
2025-Q1	Unchanged	2.3M	0.0%	$2.9M	0.0%	—
2024-Q4	Unchanged	2.3M	0.0%	$2.4M	0.0%	—
2024-Q3	Unchanged	2.3M	0.0%	$267.2M	1.1%	—

HAHALOZYME THERAPEUTICS INC